Global and China Choroidal Neovascularization Drug Market Insights, Forecast to 2026

Global and China Choroidal Neovascularization Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Choroidal Neovascularization Drug Product Introduction
1.2 Market Segments
1.3 Key Choroidal Neovascularization Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Choroidal Neovascularization Drug Market Size Growth Rate by Type
1.4.2 AVMOC-001
1.4.3 BB-3
1.4.4 BBT-007
1.4.5 DG-3
1.4.6 Entolimod
1.4.7 EWA-001
1.4.8 Others
1.5 Market by Application
1.5.1 Global Choroidal Neovascularization Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Choroidal Neovascularization Drug Market Size, Estimates and Forecasts
2.1.1 Global Choroidal Neovascularization Drug Revenue 2015-2026
2.1.2 Global Choroidal Neovascularization Drug Sales 2015-2026
2.2 Global Choroidal Neovascularization Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Choroidal Neovascularization Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Choroidal Neovascularization Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Choroidal Neovascularization Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Choroidal Neovascularization Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Choroidal Neovascularization Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Choroidal Neovascularization Drug Revenue Forecast by Region (2021-2026)
3 Global Choroidal Neovascularization Drug Competitor Landscape by Players
3.1 Global Top Choroidal Neovascularization Drug Sales by Manufacturers
3.1.1 Global Choroidal Neovascularization Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Choroidal Neovascularization Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Choroidal Neovascularization Drug Manufacturers by Revenue
3.2.1 Global Choroidal Neovascularization Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Choroidal Neovascularization Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Choroidal Neovascularization Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Choroidal Neovascularization Drug Revenue in 2019
3.2.5 Global Choroidal Neovascularization Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Choroidal Neovascularization Drug Price by Manufacturers
3.4 Global Choroidal Neovascularization Drug Manufacturing Base Distribution, Product Types
3.4.1 Choroidal Neovascularization Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Choroidal Neovascularization Drug Product Type
3.4.3 Date of International Manufacturers Enter into Choroidal Neovascularization Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Choroidal Neovascularization Drug Market Size by Type (2015-2020)
4.1.1 Global Choroidal Neovascularization Drug Sales by Type (2015-2020)
4.1.2 Global Choroidal Neovascularization Drug Revenue by Type (2015-2020)
4.1.3 Choroidal Neovascularization Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Choroidal Neovascularization Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Choroidal Neovascularization Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Choroidal Neovascularization Drug Revenue Forecast by Type (2021-2026)
4.2.3 Choroidal Neovascularization Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Choroidal Neovascularization Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Choroidal Neovascularization Drug Market Size by Application (2015-2020)
5.1.1 Global Choroidal Neovascularization Drug Sales by Application (2015-2020)
5.1.2 Global Choroidal Neovascularization Drug Revenue by Application (2015-2020)
5.1.3 Choroidal Neovascularization Drug Price by Application (2015-2020)
5.2 Choroidal Neovascularization Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Choroidal Neovascularization Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Choroidal Neovascularization Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Choroidal Neovascularization Drug Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
6.1.1 China Choroidal Neovascularization Drug Sales YoY Growth 2015-2026
6.1.2 China Choroidal Neovascularization Drug Revenue YoY Growth 2015-2026
6.1.3 China Choroidal Neovascularization Drug Market Share in Global Market 2015-2026
6.2 China Choroidal Neovascularization Drug Market Size by Players (International and Local Players)
6.2.1 China Top Choroidal Neovascularization Drug Players by Sales (2015-2020)
6.2.2 China Top Choroidal Neovascularization Drug Players by Revenue (2015-2020)
6.3 China Choroidal Neovascularization Drug Historic Market Review by Type (2015-2020)
6.3.1 China Choroidal Neovascularization Drug Sales Market Share by Type (2015-2020)
6.3.2 China Choroidal Neovascularization Drug Revenue Market Share by Type (2015-2020)
6.3.3 China Choroidal Neovascularization Drug Price by Type (2015-2020)
6.4 China Choroidal Neovascularization Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Choroidal Neovascularization Drug Sales Forecast by Type (2021-2026)
6.4.2 China Choroidal Neovascularization Drug Revenue Forecast by Type (2021-2026)
6.4.3 China Choroidal Neovascularization Drug Price Forecast by Type (2021-2026)
6.5 China Choroidal Neovascularization Drug Historic Market Review by Application (2015-2020)
6.5.1 China Choroidal Neovascularization Drug Sales Market Share by Application (2015-2020)
6.5.2 China Choroidal Neovascularization Drug Revenue Market Share by Application (2015-2020)
6.5.3 China Choroidal Neovascularization Drug Price by Application (2015-2020)
6.6 China Choroidal Neovascularization Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Choroidal Neovascularization Drug Sales Forecast by Application (2021-2026)
6.6.2 China Choroidal Neovascularization Drug Revenue Forecast by Application (2021-2026)
6.6.3 China Choroidal Neovascularization Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
7.2 North America Choroidal Neovascularization Drug Market Facts & Figures by Country
7.2.1 North America Choroidal Neovascularization Drug Sales by Country (2015-2020)
7.2.2 North America Choroidal Neovascularization Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
8.2 Europe Choroidal Neovascularization Drug Market Facts & Figures by Country
8.2.1 Europe Choroidal Neovascularization Drug Sales by Country
8.2.2 Europe Choroidal Neovascularization Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Choroidal Neovascularization Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Choroidal Neovascularization Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Choroidal Neovascularization Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
10.2 Latin America Choroidal Neovascularization Drug Market Facts & Figures by Country
10.2.1 Latin America Choroidal Neovascularization Drug Sales by Country
10.2.2 Latin America Choroidal Neovascularization Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Choroidal Neovascularization Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Choroidal Neovascularization Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Choroidal Neovascularization Drug Sales by Country
11.2.2 Middle East and Africa Choroidal Neovascularization Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Cellphire, Inc.
12.1.1 Cellphire, Inc. Corporation Information
12.1.2 Cellphire, Inc. Description and Business Overview
12.1.3 Cellphire, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cellphire, Inc. Choroidal Neovascularization Drug Products Offered
12.1.5 Cellphire, Inc. Recent Development
12.2 Chrysalis BioTherapeutics, Inc.
12.2.1 Chrysalis BioTherapeutics, Inc. Corporation Information
12.2.2 Chrysalis BioTherapeutics, Inc. Description and Business Overview
12.2.3 Chrysalis BioTherapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Products Offered
12.2.5 Chrysalis BioTherapeutics, Inc. Recent Development
12.3 Cleveland BioLabs, Inc.
12.3.1 Cleveland BioLabs, Inc. Corporation Information
12.3.2 Cleveland BioLabs, Inc. Description and Business Overview
12.3.3 Cleveland BioLabs, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Products Offered
12.3.5 Cleveland BioLabs, Inc. Recent Development
12.4 Cumberland Pharmaceuticals, Inc.
12.4.1 Cumberland Pharmaceuticals, Inc. Corporation Information
12.4.2 Cumberland Pharmaceuticals, Inc. Description and Business Overview
12.4.3 Cumberland Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Products Offered
12.4.5 Cumberland Pharmaceuticals, Inc. Recent Development
12.5 Diffusion Pharmaceuticals Inc.
12.5.1 Diffusion Pharmaceuticals Inc. Corporation Information
12.5.2 Diffusion Pharmaceuticals Inc. Description and Business Overview
12.5.3 Diffusion Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Products Offered
12.5.5 Diffusion Pharmaceuticals Inc. Recent Development
12.6 Eli Lilly and Company
12.6.1 Eli Lilly and Company Corporation Information
12.6.2 Eli Lilly and Company Description and Business Overview
12.6.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Eli Lilly and Company Choroidal Neovascularization Drug Products Offered
12.6.5 Eli Lilly and Company Recent Development
12.7 GNI Group Ltd.
12.7.1 GNI Group Ltd. Corporation Information
12.7.2 GNI Group Ltd. Description and Business Overview
12.7.3 GNI Group Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GNI Group Ltd. Choroidal Neovascularization Drug Products Offered
12.7.5 GNI Group Ltd. Recent Development
12.8 Humanetics Corporation
12.8.1 Humanetics Corporation Corporation Information
12.8.2 Humanetics Corporation Description and Business Overview
12.8.3 Humanetics Corporation Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Humanetics Corporation Choroidal Neovascularization Drug Products Offered
12.8.5 Humanetics Corporation Recent Development
12.9 INSYS Therapeutics, Inc.
12.9.1 INSYS Therapeutics, Inc. Corporation Information
12.9.2 INSYS Therapeutics, Inc. Description and Business Overview
12.9.3 INSYS Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Products Offered
12.9.5 INSYS Therapeutics, Inc. Recent Development
12.10 Meabco A/S
12.10.1 Meabco A/S Corporation Information
12.10.2 Meabco A/S Description and Business Overview
12.10.3 Meabco A/S Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Meabco A/S Choroidal Neovascularization Drug Products Offered
12.10.5 Meabco A/S Recent Development
12.11 Cellphire, Inc.
12.11.1 Cellphire, Inc. Corporation Information
12.11.2 Cellphire, Inc. Description and Business Overview
12.11.3 Cellphire, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cellphire, Inc. Choroidal Neovascularization Drug Products Offered
12.11.5 Cellphire, Inc. Recent Development
12.12 Onconova Therapeutics, Inc.
12.12.1 Onconova Therapeutics, Inc. Corporation Information
12.12.2 Onconova Therapeutics, Inc. Description and Business Overview
12.12.3 Onconova Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Onconova Therapeutics, Inc. Products Offered
12.12.5 Onconova Therapeutics, Inc. Recent Development
12.13 PharmaIN Corporation
12.13.1 PharmaIN Corporation Corporation Information
12.13.2 PharmaIN Corporation Description and Business Overview
12.13.3 PharmaIN Corporation Sales, Revenue and Gross Margin (2015-2020)
12.13.4 PharmaIN Corporation Products Offered
12.13.5 PharmaIN Corporation Recent Development
12.14 Pluristem Therapeutics Inc.
12.14.1 Pluristem Therapeutics Inc. Corporation Information
12.14.2 Pluristem Therapeutics Inc. Description and Business Overview
12.14.3 Pluristem Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Pluristem Therapeutics Inc. Products Offered
12.14.5 Pluristem Therapeutics Inc. Recent Development
12.15 ProCertus BioPharm Inc.
12.15.1 ProCertus BioPharm Inc. Corporation Information
12.15.2 ProCertus BioPharm Inc. Description and Business Overview
12.15.3 ProCertus BioPharm Inc. Sales, Revenue and Gross Margin (2015-2020)
12.15.4 ProCertus BioPharm Inc. Products Offered
12.15.5 ProCertus BioPharm Inc. Recent Development
12.16 RDD Pharma Ltd.
12.16.1 RDD Pharma Ltd. Corporation Information
12.16.2 RDD Pharma Ltd. Description and Business Overview
12.16.3 RDD Pharma Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.16.4 RDD Pharma Ltd. Products Offered
12.16.5 RDD Pharma Ltd. Recent Development
12.17 RedHill Biopharma Ltd.
12.17.1 RedHill Biopharma Ltd. Corporation Information
12.17.2 RedHill Biopharma Ltd. Description and Business Overview
12.17.3 RedHill Biopharma Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 RedHill Biopharma Ltd. Products Offered
12.17.5 RedHill Biopharma Ltd. Recent Development
12.18 RxBio, Inc.
12.18.1 RxBio, Inc. Corporation Information
12.18.2 RxBio, Inc. Description and Business Overview
12.18.3 RxBio, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.18.4 RxBio, Inc. Products Offered
12.18.5 RxBio, Inc. Recent Development
12.19 Soligenix, Inc.
12.19.1 Soligenix, Inc. Corporation Information
12.19.2 Soligenix, Inc. Description and Business Overview
12.19.3 Soligenix, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Soligenix, Inc. Products Offered
12.19.5 Soligenix, Inc. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Choroidal Neovascularization Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Choroidal Neovascularization Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Choroidal Neovascularization Drug Market Segments
Table 2. Ranking of Global Top Choroidal Neovascularization Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Choroidal Neovascularization Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AVMOC-001
Table 5. Major Manufacturers of BB-3
Table 6. Major Manufacturers of BBT-007
Table 7. Major Manufacturers of DG-3
Table 8. Major Manufacturers of Entolimod
Table 9. Major Manufacturers of EWA-001
Table 10. Major Manufacturers of Others
Table 11. Global Choroidal Neovascularization Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Choroidal Neovascularization Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Choroidal Neovascularization Drug Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Choroidal Neovascularization Drug Sales Market Share by Regions (2015-2020)
Table 15. Global Choroidal Neovascularization Drug Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Choroidal Neovascularization Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 17. Global Choroidal Neovascularization Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Choroidal Neovascularization Drug Sales Share by Manufacturers (2015-2020)
Table 19. Global Choroidal Neovascularization Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Choroidal Neovascularization Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Choroidal Neovascularization Drug as of 2019)
Table 21. Choroidal Neovascularization Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Choroidal Neovascularization Drug Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Choroidal Neovascularization Drug Price (2015-2020) (USD/Pcs)
Table 24. Choroidal Neovascularization Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Choroidal Neovascularization Drug Product Type
Table 26. Date of International Manufacturers Enter into Choroidal Neovascularization Drug Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Choroidal Neovascularization Drug Sales by Type (2015-2020) (K Pcs)
Table 29. Global Choroidal Neovascularization Drug Sales Share by Type (2015-2020)
Table 30. Global Choroidal Neovascularization Drug Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Choroidal Neovascularization Drug Revenue Share by Type (2015-2020)
Table 32. Choroidal Neovascularization Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Choroidal Neovascularization Drug Sales Share by Type (2021-2026)
Table 34. Global Choroidal Neovascularization Drug Sales by Application (2015-2020) (K Pcs)
Table 35. Global Choroidal Neovascularization Drug Sales Share by Application (2015-2020)
Table 36. Global Choroidal Neovascularization Drug Sales Share by Application (2021-2026)
Table 37. Global Choroidal Neovascularization Drug Sales Market Share Forecast by Application (2021-2026)
Table 38. Global Choroidal Neovascularization Drug Revenue by Application (2015-2020) (US$ Million)
Table 39. Global Choroidal Neovascularization Drug Revenue Market Share Forecast by Application (2021-2026)
Table 40. China Choroidal Neovascularization Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 41. China Choroidal Neovascularization Drug Sales Share by Company (2015-2020)
Table 42. China Choroidal Neovascularization Drug Revenue (US$ Million) by Company (2015-2020)
Table 43. China Choroidal Neovascularization Drug Sales (K Pcs) by Type (2015-2020)
Table 44. China Choroidal Neovascularization Drug Sales Share by Type (2015-2020)
Table 45. China Choroidal Neovascularization Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 46. China Choroidal Neovascularization Drug Price (K Pcs) by Type (2015-2020)
Table 47. China Choroidal Neovascularization Drug Sales (K Pcs) by Type (2021-2026)
Table 48. China Choroidal Neovascularization Drug Sales Share by Type (2021-2026)
Table 49. China Choroidal Neovascularization Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 50. China Choroidal Neovascularization Drug Revenue Share by Type (2021-2026)
Table 51. China Choroidal Neovascularization Drug Price (K Pcs) by Type (2021-2026)
Table 52. China Choroidal Neovascularization Drug Sales (K Pcs) by Application (2015-2020)
Table 53. China Choroidal Neovascularization Drug Sales Share by Application (2015-2020)
Table 54. China Choroidal Neovascularization Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 55. China Choroidal Neovascularization Drug Sales (K Pcs) by Application (2021-2026)
Table 56. China Choroidal Neovascularization Drug Sales Share by Application (2021-2026)
Table 57. China Choroidal Neovascularization Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 58. China Choroidal Neovascularization Drug Revenue Share by Application (2021-2026)
Table 59. North America Choroidal Neovascularization Drug Sales by Country (2015-2020) (K Pcs)
Table 60. North America Choroidal Neovascularization Drug Sales Market Share by Country (2015-2020)
Table 61. North America Choroidal Neovascularization Drug Revenue by Country (2015-2020) (US$ Million)
Table 62. North America Choroidal Neovascularization Drug Revenue Market Share by Country (2015-2020)
Table 63. Europe Choroidal Neovascularization Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Europe Choroidal Neovascularization Drug Sales Market Share by Country (2015-2020)
Table 65. Europe Choroidal Neovascularization Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Europe Choroidal Neovascularization Drug Revenue Market Share by Country (2015-2020)
Table 67. Asia Pacific Choroidal Neovascularization Drug Sales by Region (2015-2020) (K Pcs)
Table 68. Asia Pacific Choroidal Neovascularization Drug Sales Market Share by Region (2015-2020)
Table 69. Asia Pacific Choroidal Neovascularization Drug Revenue by Region (2015-2020) (US$ Million)
Table 70. Asia Pacific Choroidal Neovascularization Drug Revenue Market Share by Region (2015-2020)
Table 71. Latin America Choroidal Neovascularization Drug Sales by Country (2015-2020) (K Pcs)
Table 72. Latin America Choroidal Neovascularization Drug Sales Market Share by Country (2015-2020)
Table 73. Latin Americaa Choroidal Neovascularization Drug Revenue by Country (2015-2020) (US$ Million)
Table 74. Latin America Choroidal Neovascularization Drug Revenue Market Share by Country (2015-2020)
Table 75. Middle East and Africa Choroidal Neovascularization Drug Sales by Country (2015-2020) (K Pcs)
Table 76. Middle East and Africa Choroidal Neovascularization Drug Sales Market Share by Country (2015-2020)
Table 77. Middle East and Africa Choroidal Neovascularization Drug Revenue by Country (2015-2020) (US$ Million)
Table 78. Middle East and Africa Choroidal Neovascularization Drug Revenue Market Share by Country (2015-2020)
Table 79. Cellphire, Inc. Corporation Information
Table 80. Cellphire, Inc. Description and Business Overview
Table 81. Cellphire, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Cellphire, Inc. Choroidal Neovascularization Drug Product
Table 83. Cellphire, Inc. Recent Development
Table 84. Chrysalis BioTherapeutics, Inc. Corporation Information
Table 85. Chrysalis BioTherapeutics, Inc. Description and Business Overview
Table 86. Chrysalis BioTherapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Chrysalis BioTherapeutics, Inc. Product
Table 88. Chrysalis BioTherapeutics, Inc. Recent Development
Table 89. Cleveland BioLabs, Inc. Corporation Information
Table 90. Cleveland BioLabs, Inc. Description and Business Overview
Table 91. Cleveland BioLabs, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Cleveland BioLabs, Inc. Product
Table 93. Cleveland BioLabs, Inc. Recent Development
Table 94. Cumberland Pharmaceuticals, Inc. Corporation Information
Table 95. Cumberland Pharmaceuticals, Inc. Description and Business Overview
Table 96. Cumberland Pharmaceuticals, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Cumberland Pharmaceuticals, Inc. Product
Table 98. Cumberland Pharmaceuticals, Inc. Recent Development
Table 99. Diffusion Pharmaceuticals Inc. Corporation Information
Table 100. Diffusion Pharmaceuticals Inc. Description and Business Overview
Table 101. Diffusion Pharmaceuticals Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Diffusion Pharmaceuticals Inc. Product
Table 103. Diffusion Pharmaceuticals Inc. Recent Development
Table 104. Eli Lilly and Company Corporation Information
Table 105. Eli Lilly and Company Description and Business Overview
Table 106. Eli Lilly and Company Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Eli Lilly and Company Product
Table 108. Eli Lilly and Company Recent Development
Table 109. GNI Group Ltd. Corporation Information
Table 110. GNI Group Ltd. Description and Business Overview
Table 111. GNI Group Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. GNI Group Ltd. Product
Table 113. GNI Group Ltd. Recent Development
Table 114. Humanetics Corporation Corporation Information
Table 115. Humanetics Corporation Description and Business Overview
Table 116. Humanetics Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Humanetics Corporation Product
Table 118. Humanetics Corporation Recent Development
Table 119. INSYS Therapeutics, Inc. Corporation Information
Table 120. INSYS Therapeutics, Inc. Description and Business Overview
Table 121. INSYS Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. INSYS Therapeutics, Inc. Product
Table 123. INSYS Therapeutics, Inc. Recent Development
Table 124. Meabco A/S Corporation Information
Table 125. Meabco A/S Description and Business Overview
Table 126. Meabco A/S Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Meabco A/S Product
Table 128. Meabco A/S Recent Development
Table 129. Neumedicines Inc. Corporation Information
Table 130. Neumedicines Inc. Description and Business Overview
Table 131. Neumedicines Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Neumedicines Inc. Product
Table 133. Neumedicines Inc. Recent Development
Table 134. Onconova Therapeutics, Inc. Corporation Information
Table 135. Onconova Therapeutics, Inc. Description and Business Overview
Table 136. Onconova Therapeutics, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Onconova Therapeutics, Inc. Product
Table 138. Onconova Therapeutics, Inc. Recent Development
Table 139. PharmaIN Corporation Corporation Information
Table 140. PharmaIN Corporation Description and Business Overview
Table 141. PharmaIN Corporation Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 142. PharmaIN Corporation Product
Table 143. PharmaIN Corporation Recent Development
Table 144. Pluristem Therapeutics Inc. Corporation Information
Table 145. Pluristem Therapeutics Inc. Description and Business Overview
Table 146. Pluristem Therapeutics Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 147. Pluristem Therapeutics Inc. Product
Table 148. Pluristem Therapeutics Inc. Recent Development
Table 149. ProCertus BioPharm Inc. Corporation Information
Table 150. ProCertus BioPharm Inc. Description and Business Overview
Table 151. ProCertus BioPharm Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 152. ProCertus BioPharm Inc. Product
Table 153. ProCertus BioPharm Inc. Recent Development
Table 154. RDD Pharma Ltd. Corporation Information
Table 155. RDD Pharma Ltd. Description and Business Overview
Table 156. RDD Pharma Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 157. RDD Pharma Ltd. Product
Table 158. RDD Pharma Ltd. Recent Development
Table 159. RedHill Biopharma Ltd. Corporation Information
Table 160. RedHill Biopharma Ltd. Description and Business Overview
Table 161. RedHill Biopharma Ltd. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 162. RedHill Biopharma Ltd. Product
Table 163. RedHill Biopharma Ltd. Recent Development
Table 164. RxBio, Inc. Corporation Information
Table 165. RxBio, Inc. Description and Business Overview
Table 166. RxBio, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 167. RxBio, Inc. Product
Table 168. RxBio, Inc. Recent Development
Table 169. Soligenix, Inc. Corporation Information
Table 170. Soligenix, Inc. Description and Business Overview
Table 171. Soligenix, Inc. Choroidal Neovascularization Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 172. Soligenix, Inc. Product
Table 173. Soligenix, Inc. Recent Development
Table 174. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 175. Key Challenges
Table 176. Market Risks
Table 177. Main Points Interviewed from Key Choroidal Neovascularization Drug Players
Table 178. Choroidal Neovascularization Drug Customers List
Table 179. Choroidal Neovascularization Drug Distributors List
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Choroidal Neovascularization Drug Product Picture
Figure 2. Global Choroidal Neovascularization Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AVMOC-001 Product Picture
Figure 4. BB-3 Product Picture
Figure 5. BBT-007 Product Picture
Figure 6. DG-3 Product Picture
Figure 7. Entolimod Product Picture
Figure 8. EWA-001 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Choroidal Neovascularization Drug Sales Market Share by Application in 2020 & 2026
Figure 11. Clinic
Figure 12. Hospital
Figure 13. Others
Figure 14. Choroidal Neovascularization Drug Report Years Considered
Figure 15. Global Choroidal Neovascularization Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Choroidal Neovascularization Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Choroidal Neovascularization Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Choroidal Neovascularization Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Choroidal Neovascularization Drug Sales Market Share by Region in 2019
Figure 20. Global Choroidal Neovascularization Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Choroidal Neovascularization Drug Revenue Market Share by Region in 2019
Figure 22. Global Choroidal Neovascularization Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Choroidal Neovascularization Drug Revenue in 2019
F

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs